A SPECIAL MEETING REVIEW EDITION: Highlights in Anti-Tumor Necrosis Factor Monitoring

Special Reporting on: Novel Infliximab and Antibody-to-lnfliximab Assays Are Predictive of Disease Activity in Patients with Crohn’s DiseaseAntibodies to Infliximab Can Either Be Persistent or Transient: A Retrospective Case-Control Study in IBD Patients Treated with Infliximab Maintenance TherapyPutting It Together: Drug Levels and Disease Activity to Tailor TherapyInfliximab Concentration and Clinical Outcome in Patients with Ulcerative Colitis